Search

Your search keyword '"Iacovelli, A."' showing total 169 results

Search Constraints

Start Over You searched for: Author "Iacovelli, A." Remove constraint Author: "Iacovelli, A." Publication Type Magazines Remove constraint Publication Type: Magazines
169 results on '"Iacovelli, A."'

Search Results

1. Oral supplementation with probiotics, potassium citrate, and magnesium in reducing crystalluria in stone formers: A phase II study

2. Tivozanib plus nivolumab versus tivozanib monotherapy in patients with renal cell carcinoma following an immune checkpoint inhibitor: results of the phase 3 TiNivo-2 Study

Catalog

Books, media, physical & digital resources

3. Discovery and Heterologous Expression of Functional 4-O-Dimethylallyl-l-tyrosine Synthases from Lichen-Forming Fungi

4. Computational and experimental validation of phthalocyanine and hypericin as effective SARS-CoV-2 fusion inhibitors

5. Existing Outside of the Binary in the Classroom.

6. A Probability-Based Optimization Approach for Entanglement Distribution and Source Position in Quantum Networks

7. A System-Level Simulation Module for Multi-UAV IRS-Assisted Communications

8. Fair Energy and Data Rate Maximization in UAV-Powered IoT-Satellite Integrated Networks

9. Germline mutations in prostate cancer: a systematic review of the evidence for personalized medicine

10. Clinico-Pathological Features Influencing the Prognostic Role of Body Mass Index in Patients With Advanced Renal Cell Carcinoma Treated by Immuno-Oncology Combinations (ARON-1)

11. The role of preoperative prostatic shape in the recovery of urinary continence after robotic radical prostatectomy: a single cohort analysis

12. Predicting acute severe toxicity for head and neck squamous cell carcinomas by combining dosimetry with a radiosensitivity biomarker: a pilot study

13. Management of metastatic urothelial carcinoma: Current approach, emerging agents, and future perspectives

14. A multicenter phase 2 single arm study of cabozantinib in patients with advanced or unresectable renal cell carcinoma pre-treated with one immune-checkpoint inhibitor: The BREAKPOINT trial (Meet-Uro trial 03)

16. Concomitant Drugs Prognostic Score in Patients With Metastatic Renal Cell Carcinoma Receiving Ipilimumab and Nivolumab in the Compassionate Use Program in Italy: Brief Communication

17. The hemodynamic performance of balloon-expandable aortic bioprostheses in the elderly: a comparison between rapid deployment and transcatheter implantation

18. 2022 ADG Production Design Initiative Program.

19. Cyanidin-3-0-β-glucoside and protocatechuic acid exert insulin-like effects by upregulating PPARγ activity in human omental adipocytes

21. Maintenance or consolidation therapy in small-cell lung cancer: an updated systematic review and meta-analysis.

22. Efficacy and Safety of Telaglenastat Plus Cabozantinib vs Placebo Plus Cabozantinib in Patients With Advanced Renal Cell Carcinoma: The CANTATA Randomized Clinical Trial

23. Primary Tumor Shrinkage and the Effect on Metastatic Disease and Outcomes in Patients With Advanced Kidney Cancer With Intermediate or Poor Prognosis Treated With Nivolumab Plus Ipilimumab or Cabozantinib

24. The microbiological profile of patients with Fournier’s gangrene: A retrospective multi-institutional cohort study

25. Ultrabroadband competition in two-sided markets

26. MDM2 gene amplification as selection tool for innovative targeted approaches in PD-L1 positive or negative muscle-invasive urothelial bladder carcinoma

28. Inside the Hurricane Center

29. Patient Safety and Quality Improvement Act.

30. The use of a panel of monoclonal antibodies can lower false-negative diagnoses of peritoneal washing in ovarian tumors

31. Diagnostic pathway of the biopsy-naïve patient suspected for prostate cancer: Real-life scenario when multiparametric Magnetic Resonance Imaging is not centralized

32. Clinical Outcomes and Prognostic Factors in Patients With Penile Carcinoma: A Sub-Analysis From Meet-URO 23 (I-RARE) Registry Study

33. Metastatic Renal Cell Carcinoma Rapidly Progressive to Sunitinib: What to Do Next?

34. Antifungal Effect of All-transRetinoic Acid against Aspergillus fumigatusIn Vitroand in a Pulmonary Aspergillosis In VivoModel

35. Ungewöhnliche Manifestationsform einer allergischen bronchopulmonalen Aspergillose während des COVID-19-Lockdowns. Ein Fallbericht

36. Correlation Between Immune-related Adverse Event (IRAE) Occurrence and Clinical Outcome in Patients With Metastatic Renal Cell Carcinoma (mRCC) Treated With Nivolumab: IRAENE Trial, an Italian Multi-institutional Retrospective Study

37. The prognostic value of pain in castration-sensitive prostate cancer

40. Adverse events related to abiraterone and enzalutamide treatment: analysis of the EudraVigilance database and meta-analysis of registrational phase III studies

41. Multimodel preclinical platform predicts clinical response of melanoma to immunotherapy

42. The Anticancer Efficacy of Immune Checkpoint Inhibitors According to Patients’ Age: A Systematic Review and Meta-Analysis

43. Prognostic role of primary tumor, nodal neck, and retropharyngeal GTVs for unresectable sinonasal cancers treated with IMRT and chemotherapy

46. PD-L1 Expression in De Novo Metastatic Castration-sensitive Prostate Cancer

47. Probing the Functional Topology of a pH-Dependent Triple Helix DNA Nanoswitch Family through Gaussian Accelerated MD Simulation

48. Prevalence of Fatigue in Head and Neck Cancer Survivors

49. Results From a Large, Multicenter, Retrospective Analysis On Radium223 Use in Metastatic Castration-resistant Prostate Cancer (mCRPC) in the Triveneto Italian Region

50. Second-line therapy for metastatic urothelial carcinoma: Defining the best treatment option among immunotherapy, chemotherapy, and antiangiogenic targeted therapies. A systematic review and meta-analysis